Inserm UMRS1162, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France.
RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653 Brno, Czech Republic.
Int J Mol Sci. 2018 Nov 27;19(12):3757. doi: 10.3390/ijms19123757.
Ribosome and protein synthesis are major metabolic events that control cellular growth and proliferation. Impairment in ribosome biogenesis pathways and mRNA translation is associated with pathologies such as cancer and developmental disorders. Processes that control global protein synthesis are tightly regulated at different levels by numerous factors and linked with multiple cellular signaling pathways. Several of these merge on the growth promoting factor c-Myc, which induces ribosome biogenesis by stimulating Pol I, Pol II, and Pol III transcription. However, how cells sense and respond to mRNA translation stress is not well understood. It was more recently shown that mRNA translation stress activates c-Myc, through a specific induction of E2F1 synthesis via a PI3Kδ-dependent pathway. This review focuses on how this novel feedback pathway stimulates cellular growth and proliferation pathways to synchronize protein synthesis with ribosome biogenesis. It also describes for the first time the oncogenic activity of the mRNA, and not the encoded protein.
核糖体和蛋白质合成是控制细胞生长和增殖的主要代谢事件。核糖体生物发生途径和 mRNA 翻译的损伤与癌症和发育障碍等疾病有关。控制全局蛋白质合成的过程在不同水平受到多种因素的严格调节,并与多个细胞信号通路相关联。其中一些过程集中在生长促进因子 c-Myc 上,它通过刺激 Pol I、Pol II 和 Pol III 转录来诱导核糖体生物发生。然而,细胞如何感知和响应 mRNA 翻译应激还不是很清楚。最近的研究表明,mRNA 翻译应激通过 PI3Kδ 依赖性途径特异性诱导 E2F1 的合成来激活 c-Myc。这篇综述重点介绍了这种新的反馈途径如何刺激细胞生长和增殖途径,使蛋白质合成与核糖体生物发生同步。它还首次描述了 mRNA 的致癌活性,而不是编码蛋白的活性。